HCA Healthcare (NYSE:HCA) Price Target Raised to $381.00

Posted by Stanley Muller on Aug 3rd, 2026

HCA Healthcare (NYSE:HCA – Get Free Report) had its target price upped by equities researchers at Wells Fargo & Company from $369.00 to $381.00 in a report released on Monday,Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price target points to a potential downside of 7.79% from the stock’s previous close.

Several other equities research analysts have also issued reports on HCA. Royal Bank Of Canada reissued an “outperform” rating and set a $435.00 price objective on shares of HCA Healthcare in a research note on Monday, July 27th. Wall Street Zen lowered HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. UBS Group decreased their price target on shares of HCA Healthcare from $635.00 to $579.00 and set a “buy” rating for the company in a research note on Monday, July 27th. Robert W. Baird dropped their target price on shares of HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating on the stock in a report on Monday, July 27th. Finally, Leerink Partners lowered their price objective on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Fourteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $465.59.

Read Our Latest Research Report on HCA Healthcare

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $413.19 on Monday. The firm has a market cap of $89.46 billion, a PE ratio of 13.84, a price-to-earnings-growth ratio of 1.40 and a beta of 1.10. The firm’s fifty day moving average is $387.06 and its 200-day moving average is $450.99. HCA Healthcare has a 52 week low of $353.99 and a 52 week high of $556.52.

HCA Healthcare (NYSE:HCA – Get Free Report) last posted its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The firm had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $6.84 EPS. Sell-side analysts forecast that HCA Healthcare will post 29.45 EPS for the current year.

Institutional Investors Weigh In On HCA Healthcare

Hedge funds have recently modified their holdings of the business. Sumitomo Life Insurance Co. boosted its position in HCA Healthcare by 1.0% during the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock valued at $946,000 after acquiring an additional 20 shares in the last quarter. MJP Associates Inc. ADV boosted its position in shares of HCA Healthcare by 2.9% in the 4th quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after purchasing an additional 21 shares in the last quarter. Cary Street Partners Investment Advisory LLC lifted its position in HCA Healthcare by 7.5% during the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock worth $140,000 after acquiring an additional 21 shares during the period. Anchyra Partners LLC boosted its holdings in shares of HCA Healthcare by 3.7% in the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock valued at $278,000 after acquiring an additional 21 shares during the last quarter. Finally, Plato Investment Management Ltd boosted its stake in shares of HCA Healthcare by 0.6% in the fourth quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock worth $1,833,000 after buying an additional 22 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Company Profile

(Get Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.